USRE30007E - Hematocrit measurements by electrical conductivity - Google Patents

Hematocrit measurements by electrical conductivity Download PDF

Info

Publication number
USRE30007E
USRE30007E US05/717,381 US71738176A USRE30007E US RE30007 E USRE30007 E US RE30007E US 71738176 A US71738176 A US 71738176A US RE30007 E USRE30007 E US RE30007E
Authority
US
United States
Prior art keywords
electrodes
fluid sample
output
sample
voltage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US05/717,381
Inventor
Robert R. Steuer
Glenn G. Enke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
United States Surgical Corp
Original Assignee
United States Surgical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by United States Surgical Corp filed Critical United States Surgical Corp
Application granted granted Critical
Publication of USRE30007E publication Critical patent/USRE30007E/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/49Blood

Definitions

  • This invention relates to an improved, simple method and apparatus (portable) for a direct digital display of the electrical conductance of body fluids, specifically, the hematocrit determination of whole blood specimens.
  • Prior art techniques include the classical hematocrit measurement method by centrifugation of blood samples contained in capillary action tubes and then visually measure the relative packed cell height to the total blood sample height. This time consuming method has disadvantages which are well known to those skilled in the art; specifically, the inaccuracies due to technician errors resulting from inadequate sample centrifugation time and visual interpretation.
  • a second technique computes the hematocrit value from the product of the mean cell volume and the red cell number.
  • the mean cell volume is determined and simultaneously count the number of red cells diluted in a specific volume of fluid.
  • An electrical conductance technique is utilized to evaluate the mean cell volume and the red cell number; it may give spurious results because of dilution errors and errors due to counting particles other than red cells, i.e., white cells or more than one cell at a time, such as the doublets or triplets.
  • This invention therefore, has the following objects to provide for an improved method and portable apparatus for the direct digital display and simplified measurement of the whole blood hematocrit.
  • This technique provides two types of simple to use and easy to clean electrode probe assemblies which probes are to be used by either: (1) diping the probe directly into a test tube filled with anti-coagulated blood specimen, or: (2) placing one drop of blood onto its surface, covering the surface and the blood with a cover slip and measuring the hematocrit instantly.
  • Provisions are made whereby electrode polarization tendencies are eliminated and furthermore the sample temperature from 68° F. to 104° F. is compensated for immediately by the thermistor element which is included within the probe assembly.
  • a further object is to provide a solution to the Fricke, Curtis and Maxwell equations relating the whole blood conductivity to the hematocrit of the sample by means of an exponential approximation to the said equation.
  • Another object provides for maintaining uniformity between individual observers and to alert said observers automatically of insufficient battery power and/or poor solution-electrode contact.
  • a provision is made for obtaining a hemoglobin estimate as derived from the measured hematocrit value assuming the sample to have normal cell indices.
  • FIG. 1a is a schematic diagram of the electrical sample measurement circuit.
  • FIG. 1b is a schematic diagram of the electrical circuit performing the non-linear and temperature compensation functions.
  • FIG. 1c is a schematic diagram of the electrical analog to digital conversion, display and associated control circuitry.
  • FIG. 2 is a perspective view of the external dip-electrode probe.
  • FIG. 3 is a perspective view of the external one-drop, "fingerstick,” probe with the required microscope coverslip in place.
  • FIG. 2 which illustrates one preferred embodiment of the dip-electrode probe
  • 23 represents its protective outer stainless steel shell.
  • the stainless steel ring-like electrode surfaces 21 and 22 are insulated by epoxy plastic 20 and are electrically connected to the circuit shown in FIG. 1a, at 39.
  • a negative coefficient thermistor element 19 is embedded flush within the insulator 20 and electrically connected to the circuit shown in FIG. 1b, at 67.
  • the dip-electrode probe is to be immersed in a fixed-dimension test tube containing a pre-anticoagulated whole blood specimen wherein the anticoagulant, EDTA, concentration is not more than 2 milligram per milliliter of blood.
  • FIG. 3 which illustrates one preferred embodiment of the one-drop, "fingerstick,” probe, 28 shows its outer protective stainless steel shell.
  • a fixed volume of whole blood is enclosed between the circumferential stainless steel electrodes 26 and 27 beneath the bottom surface of coverslip 25 and above the top surface of the epoxy plastic insulator 81. Electrodes 26 and 27 are electrically connected to the circuit shown in FIG. 1a, at 39.
  • a negative temperature coefficient thermistor element 24 is embedded flush within the epoxy plastic insulator 80 and electrically connected to the circuit shown in FIG. 1b, at 67.
  • the top edges of electrodes 26 and 27 and the top surfaces of insulators 80 are milled to be flush with the bottom surface of coverslip 25.
  • the one-drop, "fingerstick,” probe is to be used by placing one drop of whole blood with anticoagulant, EDTA, concentrations between 0 and 2 milligrams per milliliter, onto surface 81 and immediately placing coverslip 25 onto the sample, thereby enclosing a fixed volume of sample between electrodes 26 and 27.
  • anticoagulant EDTA
  • Either the dip-electrode probe, FIG. 2, or the one-drop "finger-stick,” probe, FIG. 3, is intended to be connected to the circuit shown in FIG. 1a, at 39.
  • Each probe requires a different resistor value at 38 because of the cell-constant differences.
  • a constant current source generated by a 7 kHz sine was oscillator 29, an operational amplifier (op amp) 31 and current defining resistor 38, is applied to the sample probe 39 to develop a voltage of approximately 2 to 7 volts peak to peak which is linearly related to the electrical resistance of the sample.
  • op amp operational amplifier
  • a separate electrical path 32 in parallel with the sample probe 39 conducts any DC component that may be required for DC stabilization of op amp 31.
  • Capacitor 30 minimizes the amount of the DC component required in the negative feedback path.
  • tuning elements 33 and 40 are inserted ahead of the variable gain op amp 34. Voltage gain is adjusted by potentiometer 44 in order to accomodate variations in electrode dimensions.
  • the output voltage of op amp 31 contains both a variable component from the sample probe 39 and a constant component from the current defining resistor 38, it is necessary to subtract a fixed voltage from this output voltage.
  • plasma does not exhibit zero resistance it is necessary to subtract an additional fixed component such that a zero voltage is achieved at the output of op amp 45, A, when the sample probe is measuring plasma.
  • the required amount of fixed voltage is applied to the opposite input of differential op amp 45, and is adjusted by potentiometer 46, where resistors 35, 36 and 43 are used to form this symmetrical differential op amp circuit.
  • the output voltage A from op amp 45 is half-wave rectified into a negative DC voltage, clamped at the output voltage of op amp 56, which is approximately the positive supply voltage C of the voltage controlled oscillator (VCO) 1, whose control voltage is obtained at B.
  • the output voltage of op amp 53 and B is approximately at C when plasma is sampled, causing VCO 1 to oscillate at a very low frequency giving a digital reading of zero.
  • a sample with high hematocrit value causes the output voltage of op amp 53 to swing negative, a maximum of -4.0 volts, and B to reach a minimum of +2.3 volts, causing the VCO 1 to oscillate near its maximum frequency, giving a high digital reading.
  • the forward-biased diode-resistor network 65, 52, 54, 55, 57, and 58 is used to provide an inverse mapping, that is, a logarithmic transfer function, to achieve an exponential approximation to the Fricke, Curtis and Maxwell equation.
  • Op amp 56 operating at unity gain, drives a voltage reference bus for the diode-resistor network and the half-wave rectifier circuit to enable a temperature compensating voltage to be subtracted from the VCO control voltge B.
  • Potentiometer 61 adjusts the amount of temperature correction that is applied to op amp 56 from the thermistor amplification circuit, op amps 71 and 77.
  • thermistor 67 in contact with the sample, is employed to increase the hematocrit reading of the instrument, which would otherwise occur. Because thermistor 67 has a negative temperature coefficient, an increase in temperature causes a corresponding increase in the amount of current it conducts, since op amp 71 applies a constant voltage to it. Also the voltage drop across potentiometer 66, which is the sole current path to 67, increases with temperature. The output from op amp 71 is the sum of the thermistor supply voltage and the temperature varying voltage across 66 and is inverted by differential op amp 77 before being applied to potentiometer 61 such that an increase in temperature causes the output of 77 to move away from the voltage at C.
  • the resistors 64, 68 and 74 are used to apply a positive voltage, varying inversely with sample resistance, to thermistor 67 through op amp 71 so that the amount of temperature compensation introduced by 67 is inversely proportional to the hematocrit.
  • Potentiometer 66 is adjusted to equal the resistance of 67 at the lowest sample temperature permitted, 68° F., causing the output voltage of op amp 71 to be twice its positive input voltage.
  • Equal valued resistors 68 and 76 are used to reduce the output voltage of op amp 71 by one-half, before it is applied to the negative input of differential op amp 77.
  • the positive input of 77 is connected to the positive input voltage of 71 to eliminate this voltage from the thermistor output. Hence, at 68° F., no temperature compensation occurs, regardless of sample resistance.
  • VCO 1 oscillates at a frequency that is linearly related to the analog voltage difference between C and B and this resulting frequency determines the digital display count in 79.
  • a fixed-period single-shot multivibrator 78 triggered by multivibrator 16, is used to gate the output of 1 into counter 3 and thence to D of 79, wherein the counters of 79 are reset by a pulse of M which occurs at the beginning of the period of 78 and sampled by a pulse of E which occurs at the end of the period of 78.
  • Schmitt trigger 12 which sets when the voltage at A exceeds a maximum, blocks the VCO output at NAND gate 2 and causes a reading of 0.0. Reimmersing the probe into the sample clears 12, which also triggers the 10 second multivibrator 15 and reenables NAND gate 2 allowing the VCO signal to reach counter 3. Only during the period of multivibrator 15 the output of multivibrator 78 and hence 10 seconds after immersing the probe in the sample the count is held continuously.
  • Counter 3 is manually selected by switch 82 to either divide by 2 for hematocrit readings or divide by 6 for the hemoglobin estimates causing the display value in the hemoglobin mode to be one-third of the measured hematocrit value.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Ecology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Method and apparatus for determining the hematocrit of blood samples from the electrical conductance of whole blood by means of a portable, simple to use instrument with a digital readout. A dip-electrode-probe and/or a "fingerstick"-probe, requiring one drop of blood, have been developed to provide an easy to use and clean electrode system. Electronic improvements further provide for uniformity of readings between observers, automatic operator alert when poor sample contact or insufficient battery power, an exponential solution to the Fricke, Curtis and Maxwell equations and further eliminates electrode polarization by providing a separate DC path to conduct any DC component in the sine-wave signal. A provision is also made to estimate the hemoglobin value from the measured hematocrit.

Description

BACKGROUND AND SUMMARY
This invention relates to an improved, simple method and apparatus (portable) for a direct digital display of the electrical conductance of body fluids, specifically, the hematocrit determination of whole blood specimens.
There are a variety of existing methods and apparatus used for hematocrit determinations but no prior method and/or apparatus exists which determines the hematocrit of blood with a portable, digital display form which only requires diping the electrode-probe into a test tube, or by only placing one drop of blood onto the electrode surfaces, and within 10 seconds have high accuracy, reproducibility and still maintain simplicity of use and ease of electrode cleaning.
Prior art techniques include the classical hematocrit measurement method by centrifugation of blood samples contained in capillary action tubes and then visually measure the relative packed cell height to the total blood sample height. This time consuming method has disadvantages which are well known to those skilled in the art; specifically, the inaccuracies due to technician errors resulting from inadequate sample centrifugation time and visual interpretation.
A second technique computes the hematocrit value from the product of the mean cell volume and the red cell number. By measuring the average population size of the red cells the mean cell volume is determined and simultaneously count the number of red cells diluted in a specific volume of fluid. An electrical conductance technique is utilized to evaluate the mean cell volume and the red cell number; it may give spurious results because of dilution errors and errors due to counting particles other than red cells, i.e., white cells or more than one cell at a time, such as the doublets or triplets.
Other systems measuring the hematocrit by means of electrical conductivity of whole blood may suffer from the inherent errors of bridge balancing circuitry, electrodes which are cumbersome to use and/or difficult to clean; other systems may have errors due to inadequate sample temperature compensation, inadequate polarization and reactance compensation and no non-linear compensation.
This invention, therefore, has the following objects to provide for an improved method and portable apparatus for the direct digital display and simplified measurement of the whole blood hematocrit. This technique provides two types of simple to use and easy to clean electrode probe assemblies which probes are to be used by either: (1) diping the probe directly into a test tube filled with anti-coagulated blood specimen, or: (2) placing one drop of blood onto its surface, covering the surface and the blood with a cover slip and measuring the hematocrit instantly.
Provisions are made whereby electrode polarization tendencies are eliminated and furthermore the sample temperature from 68° F. to 104° F. is compensated for immediately by the thermistor element which is included within the probe assembly.
A further object is to provide a solution to the Fricke, Curtis and Maxwell equations relating the whole blood conductivity to the hematocrit of the sample by means of an exponential approximation to the said equation.
Another object provides for maintaining uniformity between individual observers and to alert said observers automatically of insufficient battery power and/or poor solution-electrode contact.
Also a provision is made for obtaining a hemoglobin estimate as derived from the measured hematocrit value assuming the sample to have normal cell indices.
DESCRIPTION OF THE DRAWINGS
The drawings presented show one preferred embodiment of our invention wherein:
FIG. 1a is a schematic diagram of the electrical sample measurement circuit.
FIG. 1b is a schematic diagram of the electrical circuit performing the non-linear and temperature compensation functions.
FIG. 1c is a schematic diagram of the electrical analog to digital conversion, display and associated control circuitry.
FIG. 2 is a perspective view of the external dip-electrode probe.
FIG. 3 is a perspective view of the external one-drop, "fingerstick," probe with the required microscope coverslip in place.
DETAILED DESCRIPTION OF THE INVENTION
Referring to FIG. 2, which illustrates one preferred embodiment of the dip-electrode probe, 23 represents its protective outer stainless steel shell. The stainless steel ring- like electrode surfaces 21 and 22 are insulated by epoxy plastic 20 and are electrically connected to the circuit shown in FIG. 1a, at 39. A negative coefficient thermistor element 19 is embedded flush within the insulator 20 and electrically connected to the circuit shown in FIG. 1b, at 67. The dip-electrode probe is to be immersed in a fixed-dimension test tube containing a pre-anticoagulated whole blood specimen wherein the anticoagulant, EDTA, concentration is not more than 2 milligram per milliliter of blood.
Referring to FIG. 3, which illustrates one preferred embodiment of the one-drop, "fingerstick," probe, 28 shows its outer protective stainless steel shell. A fixed volume of whole blood is enclosed between the circumferential stainless steel electrodes 26 and 27 beneath the bottom surface of coverslip 25 and above the top surface of the epoxy plastic insulator 81. Electrodes 26 and 27 are electrically connected to the circuit shown in FIG. 1a, at 39. A negative temperature coefficient thermistor element 24 is embedded flush within the epoxy plastic insulator 80 and electrically connected to the circuit shown in FIG. 1b, at 67. The top edges of electrodes 26 and 27 and the top surfaces of insulators 80 are milled to be flush with the bottom surface of coverslip 25. The one-drop, "fingerstick," probe is to be used by placing one drop of whole blood with anticoagulant, EDTA, concentrations between 0 and 2 milligrams per milliliter, onto surface 81 and immediately placing coverslip 25 onto the sample, thereby enclosing a fixed volume of sample between electrodes 26 and 27.
Either the dip-electrode probe, FIG. 2, or the one-drop "finger-stick," probe, FIG. 3, is intended to be connected to the circuit shown in FIG. 1a, at 39. Each probe requires a different resistor value at 38 because of the cell-constant differences.
Referring to FIG. 1a, a constant current source, generated by a 7 kHz sine was oscillator 29, an operational amplifier (op amp) 31 and current defining resistor 38, is applied to the sample probe 39 to develop a voltage of approximately 2 to 7 volts peak to peak which is linearly related to the electrical resistance of the sample. To prevent polarization of the probe electrodes, a separate electrical path 32 in parallel with the sample probe 39 conducts any DC component that may be required for DC stabilization of op amp 31. Capacitor 30 minimizes the amount of the DC component required in the negative feedback path.
To remove the capacitative reactance exhibited by the blood sample, particularly at low hematocrit values, tuning elements 33 and 40 are inserted ahead of the variable gain op amp 34. Voltage gain is adjusted by potentiometer 44 in order to accomodate variations in electrode dimensions.
Because the output voltage of op amp 31 contains both a variable component from the sample probe 39 and a constant component from the current defining resistor 38, it is necessary to subtract a fixed voltage from this output voltage. In addition, since plasma does not exhibit zero resistance it is necessary to subtract an additional fixed component such that a zero voltage is achieved at the output of op amp 45, A, when the sample probe is measuring plasma. The required amount of fixed voltage is applied to the opposite input of differential op amp 45, and is adjusted by potentiometer 46, where resistors 35, 36 and 43 are used to form this symmetrical differential op amp circuit.
Referring to FIG. 1b, the output voltage A from op amp 45 is half-wave rectified into a negative DC voltage, clamped at the output voltage of op amp 56, which is approximately the positive supply voltage C of the voltage controlled oscillator (VCO) 1, whose control voltage is obtained at B. The output voltage of op amp 53 and B is approximately at C when plasma is sampled, causing VCO 1 to oscillate at a very low frequency giving a digital reading of zero. A sample with high hematocrit value causes the output voltage of op amp 53 to swing negative, a maximum of -4.0 volts, and B to reach a minimum of +2.3 volts, causing the VCO 1 to oscillate near its maximum frequency, giving a high digital reading.
The forward-biased diode- resistor network 65, 52, 54, 55, 57, and 58 is used to provide an inverse mapping, that is, a logarithmic transfer function, to achieve an exponential approximation to the Fricke, Curtis and Maxwell equation. Op amp 56, operating at unity gain, drives a voltage reference bus for the diode-resistor network and the half-wave rectifier circuit to enable a temperature compensating voltage to be subtracted from the VCO control voltge B. Potentiometer 61 adjusts the amount of temperature correction that is applied to op amp 56 from the thermistor amplification circuit, op amps 71 and 77.
To compensate for the decrease in sample resistance with increasing temperature, thermistor 67, in contact with the sample, is employed to increase the hematocrit reading of the instrument, which would otherwise occur. Because thermistor 67 has a negative temperature coefficient, an increase in temperature causes a corresponding increase in the amount of current it conducts, since op amp 71 applies a constant voltage to it. Also the voltage drop across potentiometer 66, which is the sole current path to 67, increases with temperature. The output from op amp 71 is the sum of the thermistor supply voltage and the temperature varying voltage across 66 and is inverted by differential op amp 77 before being applied to potentiometer 61 such that an increase in temperature causes the output of 77 to move away from the voltage at C.
Because the temperature coefficient of a blood sample is inversely related to its hematocrit value, the resistors 64, 68 and 74 are used to apply a positive voltage, varying inversely with sample resistance, to thermistor 67 through op amp 71 so that the amount of temperature compensation introduced by 67 is inversely proportional to the hematocrit. Potentiometer 66 is adjusted to equal the resistance of 67 at the lowest sample temperature permitted, 68° F., causing the output voltage of op amp 71 to be twice its positive input voltage. Equal valued resistors 68 and 76 are used to reduce the output voltage of op amp 71 by one-half, before it is applied to the negative input of differential op amp 77. The positive input of 77 is connected to the positive input voltage of 71 to eliminate this voltage from the thermistor output. Hence, at 68° F., no temperature compensation occurs, regardless of sample resistance.
Referring to FIG. 1c, VCO 1 oscillates at a frequency that is linearly related to the analog voltage difference between C and B and this resulting frequency determines the digital display count in 79. A fixed-period single-shot multivibrator 78, triggered by multivibrator 16, is used to gate the output of 1 into counter 3 and thence to D of 79, wherein the counters of 79 are reset by a pulse of M which occurs at the beginning of the period of 78 and sampled by a pulse of E which occurs at the end of the period of 78.
To avoid spurious readings with the probe out of sample contact, Schmitt trigger 12, which sets when the voltage at A exceeds a maximum, blocks the VCO output at NAND gate 2 and causes a reading of 0.0. Reimmersing the probe into the sample clears 12, which also triggers the 10 second multivibrator 15 and reenables NAND gate 2 allowing the VCO signal to reach counter 3. Only during the period of multivibrator 15 the output of multivibrator 78 and hence 10 seconds after immersing the probe in the sample the count is held continuously.
Counter 3 is manually selected by switch 82 to either divide by 2 for hematocrit readings or divide by 6 for the hemoglobin estimates causing the display value in the hemoglobin mode to be one-third of the measured hematocrit value.
Although the preferred embodiment of our invention has been described herein, it is to be understood that the invention is not limited thereby, but is to be determined by the scope of the appended claims:

Claims (6)

We claim:
1. An apparatus for displaying in digital form the volume percentage of red cells in a conducting fluid sample comprising:
a. 2 spaced electrodes cooperating with said fluid sample;
b. a sinusoid alternating current source having its constant current output connected to said electrodes;
c. a variable gain amplifier having its input terminals connected to said electrodes;
d. a differential amplifier having its input terminals connected between the output of said variable gain amplifier and the constant voltage output of said alternating current source;
e. rectifying means and DC amplifier connected to the output of said differential amplifier;
f. a dynamic attenuating resistive network, whose output voltage approximates the volume percentage of red red cells in said fluid sample, driven by the output of said DC amplifier;
g. means operable to render said attenuating network output substantially independent of temperature variations of said fluid sample; and
h. digital display means driven by the output of said attenuating network to provide direct readout of either the volume percentage of red cells in said fluid sample or the hemoglobin estimate of said fluid sample.
2. The apparatus as in claim 1 wherein filtering means is provided to cause the input signal of said variable gain amplifier to be substantially free of the capacitive reactance component produced by said electrodes.
3. The apparatus as in claim 1 wherein a variable resistance is connected between said constant voltage output of said alternating current source and one input terminal of said differential amplifier, to achieve a null output of said differential amplifier when said fluid sample contains no red cells.
4. The apparatus as in claim 1 wherein said rendering means comprises a negative temperature coefficient thermistor mounted in close proximity to said fluid sample, driven by a dynamically varying DC voltage source, achieving a thermistor current jointly proportional to the temperature and the volume percentage of red cells in said fluid sample and amplifying means to convert the thermistor current to a corresponding DC voltage linearly added to the output of said attenuating network.
5. The apparatus as in claim 1 wherein said digital display means achieves the said hemoglobin estimate readout by reducing the said volume percentage of red cells readout by the ratio 3 to 1.
6. The apparatus as in claim 1 wherein said spaced electrodes comprise first and second conductive areas each having a cylindrical shape, wherein the inner surface of the first conductive area is exposed to said fluid sample and the outer surface of the second conductive area, centered within the first conductive area and of substantially less diameter, is exposed to said fluid sample, and a fixed volume of said fluid sample is confined above said conductive areas by a planar glass cover slip normal to the axis of the cylinders and below by the top surface of an insulator separating the first and second conductive areas. .Iadd. 7. An apparatus for determining a conductance characteristic of whole blood, the apparatus comprising:
base means of insulating material;
a region defined by said base means for receiving and holding a liquid sample of whole blood, said region having a volume substantially corresponding to one drop of whole blood;
first and second electrodes positioned in spaced-apart relation in said base means with the exposed portions of said electrodes being entirely within the boundaries of said region to be completely covered by and submerged in a one-drop blood sample when same is received in said region, said electrodes being configured so that the path of a current produced by the electric voltage applied between said electrodes is completely contained within the one-drop blood sample received in said region; and
means for electrically connecting said first and second electrodes to an electric circuit capable of creating and measuring a current between said electrodes to enable a characteristic of whole blood to be determined. .Iaddend..Iadd. 8. The apparatus of claim 7 further comprising a coverslip for enclosing said liquid blood sample in said region. .Iaddend..Iadd. 9. The apparatus of claim 7 further comprising temperature sensing means associated with said base and means for electrically connecting said temperature sensing means to an electrical circuit for compensating for temperature variation in said liquid blood sample. .Iaddend..Iadd. 10. The apparatus of claim 7, wherein said insulating material is an epoxy plastic. .Iaddend..Iadd. 11. The apparatus of claim 7, wherein each of said electrodes are made from stainless steel. .Iaddend.
US05/717,381 1974-08-15 1976-08-24 Hematocrit measurements by electrical conductivity Expired - Lifetime USRE30007E (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US497553A US3922598A (en) 1974-08-15 1974-08-15 Hematocrit measurements by electrical conductivity

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US497553A Reissue US3922598A (en) 1974-08-15 1974-08-15 Hematocrit measurements by electrical conductivity

Publications (1)

Publication Number Publication Date
USRE30007E true USRE30007E (en) 1979-05-22

Family

ID=23977329

Family Applications (2)

Application Number Title Priority Date Filing Date
US497553A Expired - Lifetime US3922598A (en) 1974-08-15 1974-08-15 Hematocrit measurements by electrical conductivity
US05/717,381 Expired - Lifetime USRE30007E (en) 1974-08-15 1976-08-24 Hematocrit measurements by electrical conductivity

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US497553A Expired - Lifetime US3922598A (en) 1974-08-15 1974-08-15 Hematocrit measurements by electrical conductivity

Country Status (1)

Country Link
US (2) US3922598A (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5385846A (en) * 1993-06-03 1995-01-31 Boehringer Mannheim Corporation Biosensor and method for hematocrit determination
US5983120A (en) 1995-10-23 1999-11-09 Cytometrics, Inc. Method and apparatus for reflected imaging analysis
US6262798B1 (en) 1992-09-29 2001-07-17 Board Of Regents, The University Of Texas System Method and apparatus for direct spectrophotometric measurements in unaltered whole blood
US6548017B2 (en) 1997-03-25 2003-04-15 Transonic Systems, Inc. Method for real time monitoring of blood volume in a filter
US6794877B2 (en) 2002-07-31 2004-09-21 International Technidyne Corporation Apparatus and method for analytical determinations
US20080124749A1 (en) * 2006-09-14 2008-05-29 Farnam W Edward Device and method for measuring properties of a sample
US20080195162A1 (en) * 2007-02-08 2008-08-14 Michael Lippert Implantable medical device
US20080297169A1 (en) * 2007-05-31 2008-12-04 Greenquist Alfred C Particle Fraction Determination of A Sample
US20130221986A1 (en) * 2010-11-09 2013-08-29 Harald Riegel Method for Calibrating a Conductivity Measuring Cell
US9423393B2 (en) 2002-06-28 2016-08-23 International Technidyne Corporation Analytical test cartridge; and, methods

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1048235B (en) * 1975-10-13 1980-11-20 Dasco Spa Conductivity meter for concentration determination - incorporating circuit with thermistor temperature compensation
US4123701A (en) * 1976-07-01 1978-10-31 United States Surgical Corporation Disposable sample card having a well with electrodes for testing a liquid sample
US4331923A (en) * 1979-08-06 1982-05-25 Akers Jr Raymond F Salts monitoring device
US4301414A (en) * 1979-10-29 1981-11-17 United States Surgical Corporation Disposable sample card and method of making same
DE3202067C2 (en) * 1982-01-23 1984-06-20 Holger Dr. 5100 Aachen Kiesewetter Device for determining the hematocrit value
US5869971A (en) * 1996-05-17 1999-02-09 Sendx Medical, Inc. Method and apparatus for ratiometric measurement of hematocrit
US7494816B2 (en) * 1997-12-22 2009-02-24 Roche Diagnostic Operations, Inc. System and method for determining a temperature during analyte measurement
US7018843B2 (en) * 2001-11-07 2006-03-28 Roche Diagnostics Operations, Inc. Instrument
US8148164B2 (en) 2003-06-20 2012-04-03 Roche Diagnostics Operations, Inc. System and method for determining the concentration of an analyte in a sample fluid
US20070264721A1 (en) * 2003-10-17 2007-11-15 Buck Harvey B System and method for analyte measurement using a nonlinear sample response
JP4717636B2 (en) * 2003-12-04 2011-07-06 パナソニック株式会社 Method for measuring hematocrit (Hct), sensor used therefor, and measuring apparatus
WO2005054840A1 (en) * 2003-12-04 2005-06-16 Matsushita Electric Industrial Co., Ltd. Blood component measuring method, sensor used therefor, and measuring instrument
KR101108381B1 (en) * 2004-04-19 2012-01-30 파나소닉 주식회사 Method for measuring blood components and biosensor and measuring instrument for use therein
KR101666978B1 (en) 2014-09-17 2016-10-24 주식회사 아이센스 Apparatus and Method for measuring concentration of Whole Blood Samples Using the same
CN111707589A (en) * 2020-07-10 2020-09-25 基蛋生物科技股份有限公司 HCT measuring device and method and chemiluminescence instrument provided with same

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2039219A (en) * 1933-03-17 1936-04-28 Hausser Carl Adolph Haemacytometer
US2082213A (en) * 1934-08-20 1937-06-01 O'donnell James Lloyd Water content indicator for liquid mixtures
US2215213A (en) * 1937-12-11 1940-09-17 Francis C Ellis Electrode for measuring electrolytic effects
US2611007A (en) * 1951-02-02 1952-09-16 Photoswitch Marine Division In Temperature-compensating conductivity cell
US3115602A (en) * 1960-02-01 1963-12-24 Continental Oil Co Continuous mud resistivity measuring device with electricity conductive current confining means
US3512080A (en) * 1967-06-09 1970-05-12 Emil J Hanson Electrical conductivity tester for milk with movable electrode for temperature compensation
US3593119A (en) * 1969-05-28 1971-07-13 Lubrizol Corp Electronic titrimeter
US3710778A (en) * 1971-03-15 1973-01-16 Gen Electric Blood gas sensor amplifier and testing system
US3772591A (en) * 1972-04-12 1973-11-13 Fisher Scientific Co Method and apparatus for analyzing blood properties

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2039219A (en) * 1933-03-17 1936-04-28 Hausser Carl Adolph Haemacytometer
US2082213A (en) * 1934-08-20 1937-06-01 O'donnell James Lloyd Water content indicator for liquid mixtures
US2215213A (en) * 1937-12-11 1940-09-17 Francis C Ellis Electrode for measuring electrolytic effects
US2611007A (en) * 1951-02-02 1952-09-16 Photoswitch Marine Division In Temperature-compensating conductivity cell
US3115602A (en) * 1960-02-01 1963-12-24 Continental Oil Co Continuous mud resistivity measuring device with electricity conductive current confining means
US3512080A (en) * 1967-06-09 1970-05-12 Emil J Hanson Electrical conductivity tester for milk with movable electrode for temperature compensation
US3593119A (en) * 1969-05-28 1971-07-13 Lubrizol Corp Electronic titrimeter
US3710778A (en) * 1971-03-15 1973-01-16 Gen Electric Blood gas sensor amplifier and testing system
US3772591A (en) * 1972-04-12 1973-11-13 Fisher Scientific Co Method and apparatus for analyzing blood properties

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7075628B2 (en) 1989-02-23 2006-07-11 Board Of Regents, The University Of Texas System Method and apparatus for direct spectrophotometric measurements in unaltered whole blood
US6519025B2 (en) 1989-02-23 2003-02-11 Board Of Regents, The University Of Texas System Method and apparatus for direct spectrophotometric measurements in unaltered whole blood
US20030202170A1 (en) * 1989-02-23 2003-10-30 Board Of Regents, The University Of Texas System Method and apparatus for direct spectrophotometric measurements in unaltered whole blood
US6262798B1 (en) 1992-09-29 2001-07-17 Board Of Regents, The University Of Texas System Method and apparatus for direct spectrophotometric measurements in unaltered whole blood
US5385846A (en) * 1993-06-03 1995-01-31 Boehringer Mannheim Corporation Biosensor and method for hematocrit determination
US6104939A (en) 1995-10-23 2000-08-15 Cytometrics, Inc. Method and apparatus for reflected imaging analysis
US5983120A (en) 1995-10-23 1999-11-09 Cytometrics, Inc. Method and apparatus for reflected imaging analysis
US6548017B2 (en) 1997-03-25 2003-04-15 Transonic Systems, Inc. Method for real time monitoring of blood volume in a filter
US9423393B2 (en) 2002-06-28 2016-08-23 International Technidyne Corporation Analytical test cartridge; and, methods
US6794877B2 (en) 2002-07-31 2004-09-21 International Technidyne Corporation Apparatus and method for analytical determinations
US20080124749A1 (en) * 2006-09-14 2008-05-29 Farnam W Edward Device and method for measuring properties of a sample
US7674616B2 (en) 2006-09-14 2010-03-09 Hemosense, Inc. Device and method for measuring properties of a sample
US20080195162A1 (en) * 2007-02-08 2008-08-14 Michael Lippert Implantable medical device
US8271085B2 (en) * 2007-02-08 2012-09-18 Biotronik Crm Patent Ag Implantable medical device for blood conductivity, blood impedance, and/or hematocrit measurement
US20080297169A1 (en) * 2007-05-31 2008-12-04 Greenquist Alfred C Particle Fraction Determination of A Sample
US20130221986A1 (en) * 2010-11-09 2013-08-29 Harald Riegel Method for Calibrating a Conductivity Measuring Cell
US9500735B2 (en) * 2010-11-09 2016-11-22 Endress+Hauser Conducta Gmbh+Co. Kg Method for calibrating a conductivity measuring cell

Also Published As

Publication number Publication date
US3922598A (en) 1975-11-25

Similar Documents

Publication Publication Date Title
USRE30007E (en) Hematocrit measurements by electrical conductivity
US4547735A (en) Instrument for measuring the hematocrit value of blood
US5708363A (en) Liquid conductivity measurement system using a variable-frequency AC voltage
NZ192090A (en) Measuring a chemical characteristic of a liquid with immersed electrodes ph meter
US4658207A (en) Device for measuring the water content of ink samples
US3635681A (en) Differential conductivity-measuring apparatus
US3250987A (en) Hematocrit meter
US2985826A (en) Electrical measuring apparatus
EP0145073B1 (en) Gas analysis apparatus
US3757205A (en) Conductivity measuring apparatus
US3482898A (en) Microscope system and reservoir for chemical preparations
US3849723A (en) Conductivity measuring method and apparatus
US4321544A (en) Method and improved apparatus for obtaining temperature-corrected readings of ion levels and readings of solution temperature
Barrie Measurement of very low dielectric losses at radio frequencies
US3265962A (en) Method of and apparatus for microsample conductivity measurement
US3593118A (en) Apparatus for measuring the electrical conductivity of liquids having dielectric-faced electrodes
EP0730149A2 (en) Linearized potentiometric electrode
US3980944A (en) Portable conductivity meter for artificial kidney machines
RU2073854C1 (en) Method for ion measurements
EP1473359A1 (en) Non-invasive fast assessment of bacterial load in blood and blood products
RU2094791C1 (en) Calibrated solid-electrolyte analyzer
RU2094794C1 (en) Gas generator
Gundersen et al. Low‐voltage ELF electric field measurements in ionic media
SU1083102A1 (en) Particle analyzer
SU679895A1 (en) Device for measuring complex conductivity constituents of two-pole circuits